About this trial
This study looks at whether a special wound dressing containing ozonated oil can reduce early wound inflammation after open inguinal hernia surgery. Open inguinal hernia repair is a common operation, and although infection rates are low, many patients experience redness, swelling, tenderness, or discomfort at the surgical site during the first days after surgery.
Participants undergoing elective open inguinal hernia repair will be randomly assigned to receive either an ozonated oil-impregnated dressing or a standard sterile dressing after the operation. The main outcome is the level of wound inflammation measured on the third day after surgery. Other outcomes include wound temperature, pain levels, cosmetic healing, and wound-related problems during the first 30 days.
The ozonated oil used in this study is a CE-certified medical product that is already used in routine wound care. This pilot study aims to provide preliminary data to help determine whether ozonated oil dressing may improve early wound healing compared with standard care.
Eligibility criteria
Qualifiers
Adults aged 18 to 75 years
ASA physical status I-III
Scheduled for elective, unilateral open inguinal hernia repair
Able to provide written informed consent
Disqualifiers
Emergency inguinal hernia (incarcerated or strangulated)
Recurrent inguinal hernia
Concomitant surgical procedures during the same operation
Immunosuppression or long-term systemic steroid use
Trial design
Treatments tested in this trial
- ozonated oil
- Standard Sterile Dressing